Showing results (1041-1050 of 2,811) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|January 25, 2018
Androgenetic alopecia; drug safety and therapeutic strategiesIon G Motofei, David L Rowland, Daniela L Baconi, et al.Expert Opinion on Drug Safety|March 23, 2018
A randomized, open-label, comparative, crossover trial on preference, efficacy, and safety profiles of lispro insulin u-100 versus concentrated lispro insulin u-200 in patients with type 2 diabetes mellitus: a possible contribution to greater treatment adherenceSandro Gentile, Alessandra Fusco, Sara Colarusso, et al.Expert Opinion on Drug Safety|December 22, 2018
Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)Shahariar Mohammed Fahim, Ahmed Ullah Mishuk, Ning Cheng, et al.Expert Opinion on Drug Safety|January 11, 2021
The safety of sublingual immunotherapy, can the rare systemic reactions be prevented?Carlo Cavaliere, Cristoforo Incorvaia, Elona Begvarfaj, et al.Expert Opinion on Drug Safety|June 4, 2021
What about regular hematological monitoring during clozapine treatment? A compliance analysis using the French health insurance databaseEdouard-Jules Laforgue, Marion Istvan, Marylène Guerlais, et al.Expert Opinion on Drug Safety|June 2, 2021
Prevalence, characteristics, and reporting of adverse drug reactions in an Australian hospital: a retrospective review of hospital admissions due to adverse drug reactionsRaymond Li, Kate Curtis, Syed Tabish Razi Zaidi, et al.Expert Opinion on Drug Safety|November 20, 2020
Effectiveness and sustainability of deprescribing for hospitalized older patients near end of life: a systematic reviewMagnolia Cardona, Paulina Stehlik, Peter Fawzy, et al.Expert Opinion on Drug Safety|December 17, 2020
Safety and efficacy of pharmacologic agents used for rapid tranquilization of emergency department patients with acute agitation or excited deliriumHong K Kim, James B Leonard, Brian N Corwell, et al.Expert Opinion on Drug Safety|February 18, 2020
Safety considerations when using drugs to treat pruritusKayla Fourzali, Gil YosipovitchExpert Opinion on Drug Safety|July 14, 2021
Safety considerations with new antibacterial approaches for chronic bacterial prostatitisGianpaolo Perletti, Alberto Trinchieri, Konstantinos Stamatiou, et al.Pageof 282